# Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

> **NCT00160615** · PHASE3 · COMPLETED · sponsor: **UCB Japan Co. Ltd.** · enrollment: 154 (actual)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT00160615
- **Lead sponsor:** UCB Japan Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09-12
- **Primary completion:** 2007-01-17
- **Final completion:** 2007-01-17
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2019-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160615, "Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00160615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*